Flare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine
Shintaro Yamamoto, Keisuke Nishimura, Kohei Yo, Daisuke Waki, Hiroyuki Murabe, Toshihiko Yokota
Abstract
Letters to the EditorsFlare-up of adult-onset Still's disease after receiving a second dose of BNT162b2 COVID-19 mRNA vaccine Sirs, Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are essential for controlling the ongoing coronavirus disease 2019 (COVID-19) pandemic.At present, vaccination is continuing rapidly worldwide, and many individuals with rheumatic diseases have received vaccines to prevent SARS-CoV-2 infection.However, data on the safety of SARS-CoV-2 vaccines in patients with rheumatic diseases are insufficient (1).Herein, we report a case of adult-onset Still's disease (AOSD) that relapsed after SARS-CoV-2